Marina Biotech Adds $3.3M

Marina Biotech (NASDAQ: MRNA), the Bothell, WA-based developer of RNA-based therapies, said today it has raised $3.3 million through a securities offering. Investors in the deal, who bought 1.8 million shares at $1.84 apiece, also got a subscription unit to buy another 2.4 million shares at any time over the next 16 months for no more than $2.21 a share, Marina said. If investors buy those shares, the company could raise another $5.4 million.

Trending on Xconomy